argenx SE (NAS:ARGX)
$ 356.01 -3.47 (-0.97%) Market Cap: 21.22 Bil Enterprise Value: 18.74 Bil PE Ratio: 0 PB Ratio: 5.39 GF Score: 74/100

Q4 2019 argenx SE Earnings Call Transcript

Feb 27, 2020 / 02:00PM GMT
Release Date Price: $143.54 (-4.63%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to argenx Full Year 2019 Financial Results and Fourth Quarter Business Update Conference Call. (Operator Instructions)

I would like to introduce Beth DelGiacco, Vice President of Investor Relations at argenx. Thank you. Please go ahead.

Beth DelGiacco
argenx SE - VP of IR - US

Thank you, operator. A press release with our fourth quarter business update and full year 2019 financial results was issued earlier today and can be found on the News and Events section of our website.

Before we begin, I'd like to remind you on Slide 2 that forward-looking statements may be presented during this call. These may include statements about our future expectations, clinical development, regulatory time lines, the potential success of our product candidates, financial projections and upcoming milestones. Actual results may differ materially from those indicated by these statements. Argenx is not under any obligation to update statements regarding the future or to conform those statements in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot